<DOC>
	<DOCNO>NCT02068157</DOCNO>
	<brief_summary>This phase II trial study effect interstitial photodynamic therapy patient head neck cancer come back . Interstitial photodynamic therapy use combination laser light light-sensitive drug call porfimer sodium destroy tumor . During treatment laser light use activate drug . Interstitial photodynamic therapy may effective treatment head neck cancer .</brief_summary>
	<brief_title>Interstitial Photodynamic Therapy Treating Patients With Recurrent Head Neck Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Demonstrate image-guided interstitial photodynamic therapy ( I-PDT ) dosimetry system use tailor therapy individual patient . OUTLINE : Patients receive porfimer sodium intravenously ( IV ) 3-5 minute day 0 . Patients undergo image-guided I-PDT day 2 . After completion study , patient follow 1 month , 2 month , 4 month , every 2 month 12 month .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Carcinoma , Verrucous</mesh_term>
	<mesh_term>Dihematoporphyrin Ether</mesh_term>
	<mesh_term>Trioxsalen</mesh_term>
	<criteria>Have Eastern Cooperative Oncology Group ( ECOG ) performance status = &lt; 2 Histologically confirm recurrent squamous cell carcinoma oral cavity , pharynx , ( oropharynx , larynx ) neck Tumor accessible unrestricted illumination interstitial photodynamic therapy ( PDT ) ( accessibility determine physician ) Patients chemotherapy &amp; /or target agent palliation Life expectancy least 6 month judgment physician Subjects childbearing potential must agree use adequate contraceptive method ( e.g. , hormonal barrier method birth control ; abstinence ) prior study entry 6 month last treatment ; woman become pregnant suspect pregnant partner participate study , inform treat physician immediately Subject legal representative must understand investigational nature study sign Institutional Review Board approve write informed consent form prior receive study related procedure Radiotherapy within last 2 month area treat Patients know brain metastasis exclude clinical trial Tumor invade major blood vessel ( carotid artery ) Tumor clearly show compute tomography ( CT ) scan Location extension tumor precludes effective IPDT Patients porphyria , know hypersensitivity porphyrin porphyrinlike compound While blood cell ( WBC ) &lt; 2.0 x 10^9/L Total serum bilirubin &gt; 2.0 mg/dl Serum creatinine &gt; 2 mg/dl Alkaline phosphatase ( hepatic ) &gt; 3 time upper normal limit Serum glutamic oxaloacetic transaminase ( SGOT ) &gt; 3 time upper limit normal Uncontrolled intercurrent illness include , limited , ongoing active infection , acute exacerbation congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement Pregnant nursing female subject Unwilling unable follow protocol requirement light exposure precaution Any condition Investigators ' opinion deems subject unsuitable candidate receive study drug therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>